<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A randomized, placebo-controlled study evaluated the effects multiple-doses (28 days) dipeptidyl peptidase-IV (DPP-IV) inhibitor PF-734200 on DPP-IV activity, <z:chebi fb="105" ids="17234">glucose</z:chebi>, glucagon-like <z:chebi fb="7" ids="16670">peptide</z:chebi>-1 (GLP-1), glucagon and insulin levels in 72 subjects with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>The relationship between changes in active GLP-1 and <z:chebi fb="105" ids="17234">glucose</z:chebi> during a meal test appeared non-linear </plain></SENT>
</text></document>